Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association ofCYP2C1917/17 Genotype With the Risk of Voriconazole-Associated Squamous Cell Carcinoma

16 Mar 2016

Abstract excerpt

This cohort study investigates whether lung transplant recipients with the ultrarapid-metabolizing *17 allele of CYP2C19 have an increased risk for voriconazole-associated cutaneous squamous cell carcinoma.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antifungal resistance and susceptibility
Share to Infectious Diseases and Mycology
Share to Photodynamic Therapy Research Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26982740
DOI: 10.1001/jamadermatol.2016.0351

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 11 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association ofCYP2C19*17/*17 Genotype With the Risk of Voriconazole-Associated Squamous Cell CarcinomaPMID 26982740Read ↗

Voriconazole Metabolism is Associated with the Number of Skin Cancers Per PatientSemantic proximity Read ↗

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.Semantic proximity Read ↗

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosingSemantic proximity Read ↗

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing.Semantic proximity Read ↗

Effect of cytochrome P450 2C19 genotype on voriconazole exposure in cystic fibrosis lung transplant patients.Semantic proximity Read ↗

CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.Semantic proximity Read ↗

Influence of CYP2C19*2/*17 genotype on adverse drug reactions of voriconazole in patients after allo-HSCT: a four-case report.Semantic proximity Read ↗

The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.Semantic proximity Read ↗

Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations.Semantic proximity Read ↗

High metabolic N-oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19*17/*17 genotype.Semantic proximity Read ↗

Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes.Semantic proximity Read ↗

Interaction of age and CYP2C19 genotypes on voriconazole steady-state trough concentration in Chinese patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.